Royal Philips and Netherlands-based Radboud university medical center have launched a connected digital health prototype, which allows diabetes patients and their health care providers to manage complexity of diabetes self-care.
The system has been developed based on Philips HealthSuite digital platform, which securely connects devices and collects, integrates and analyzes patient data from connected consumer and medical devices, electronic medical records, and personal health data.
Both organizations will use the new digital health prototype to focus on patients living with diabetes type 1, in the first phase.
The system, including a mobile patient app and online community, will collect and connect data from electronic medical records, multiple personal health devices such as wireless glucose meters and activity monitors, comprising patient self-reported data.
The app, through a smartphone or tablet, provides patients with continuous access to important parameters such as blood glucose levels, insulin use and nutrition, offering coaching guidance at home and on the go.
Philips healthcare informatics solutions and services CEO Jeroen Tas said: "I am excited that we are providing people with diabetes the tools to connect all of their relevant health data and devices.
"Our system allows sharing of data and experiences in one community, where they can collaborate with fellow patients and their care teams in a secure environment."
The secure online community, including enrolled patients and healthcare professionals, can interact through private messaging or shared posts within a healthcare organization’s clinical guidelines.
Philips recently obtained 510(k) approval from the US Food and Drug Administration (FDA) for its Spectral Diagnostic Suite (SpDS), which is a set of advanced visualization and analysis tools developed for the Philips IQon Spectral CT to provide better spectral viewing and advanced clinical applications capabilities.
Image: Philips and Radboud university medical center have launched new digital health prototype for diabetes patients. Photo: courtesy of Koninklijke Philips N.V.